Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly a invitro
- 30 October 1984
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 124 (2) , 416-422
- https://doi.org/10.1016/0006-291x(84)91569-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Human and rat urinary metabolites of the antitumor drug celiptium ® (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the “biooxidative alkylation” hypothesisBiochemical Pharmacology, 1983
- Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivativesJournal of Medicinal Chemistry, 1983
- o-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetateJournal of Medicinal Chemistry, 1983
- Binding of Actinomycin D to mRNA In Vivo and In VitroThe Journal of Biochemistry, 1983
- Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donorsTetrahedron Letters, 1983
- Metabolism of the anti-tumour drugsN2-methyl-9-hydroxyellipticinium acetate (NSC 264137) andN2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugatesXenobiotica, 1983
- Inhibition of ribonucleic acid polymerase activity by ellipticineBiochemical Pharmacology, 1981
- Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)Published by Springer Nature ,1980
- Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemiaChemico-Biological Interactions, 1979
- Effects of 9-hydroxy ellipticine on in vitro transcription of Trypanosoma cruzi DNAsBiochemical and Biophysical Research Communications, 1977